TAE raises $40m to develop new targeted radiotherapyMedtech firm TAE Life Sciences is developing a ground-breaking radiotherapy technology which will be able to treat hard-to-reach Share XTAE raises $40m to develop new targeted radiotherapyhttps://pharmaphorum.com/news/tae-raises-40m-develop-new-targeted-radiotherapy/
